论文信息 - A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma - 字舞流文

A Phase Ib, Open‐Label Study of Dalantercept, an Activin Receptor‐Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma

Manish R. Sharma | G. Abou-Alfa | M. Tejani | R. Miksad | M. Gutierrez | M. Sherman | S. Williamson | O. Olowokure | S. Pandya | I. E. El Dika | M. Sharma | I. El Dika